In this article (Clin Cancer Res 2011;17:100–10), which was published in the January 1, 2011 issue of Clinical Cancer Research (1), the name of the first author appeared incorrectly on the online journal. The correct name of the first author is Patricia Martin-Killias. This error has been corrected.
References
1.
Martin-Killias
P
, Stefan
N
, Rothschild
S
, Plückthun
A
, Zangemeister-Wittke
U
. A novel fusion toxin derived from an EpCAM-specific designed ankyrin repeat protein has potent antitumor activity
. Clin Cancer Res
2011
;17
:100
–10
.©2011 American Association for Cancer Research.
2011